by James Rudge, PhD, Technical Director, Neoteryx | 5 min read
An article published by Pasquale Striano et al at Giannina Gaslini Institute (IRCCS), Italy in the July 2020 issue of Molecules, reported on using Mitra® devices based on VAMS® to …
Read Storyby Neoteryx | 4 min read
Research scientists and clinical trial managers can take advantage of the technologies that doctors are using in telemedicine to access patients at home. Shipping remote specimen collection kits out to …
Read Storyby Neoteryx | 2 min read
Some young patients are subjected to a lot of blood tests. A solution to lowering the fear factor for these kids is Mitra® at-home blood collection kits. This patient-centered approach …
Read Storyby Neoteryx | 3 min read
Close monitoring of patients is essential after a kidney transplant to ensure the body is not rejecting its new organ. Kidney transplant patients typically receive therapeutic drugs post-transplant to help …
Read Storyby Neoteryx | 1 min read
When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, …
Read Storyby Neoteryx | 2 min read
Pediatric clinical trials aim at boosting public health by ensuring safety in child medications. Clinical trials involving children pose challenges distinct from those focused on adults. Approximately 40% of the …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.